Healthy Skepticism Library item: 13381

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Outterson K, Kesselheim AS.
Market-based licensing for HPV vaccines in developing countries.
Health Aff (Millwood) 2008 Jan-Feb; 27:(1):130-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/130

Abstract:

Human papillomavirus (HPV) vaccines hold great promise for preventing cervical cancer, but 93 percent of mortality worldwide occurs in low- and middle-income countries, where high vaccine costs can restrict dissemination. Current models for promoting international access to health care innovations include differential pricing, advance market commitments, and voluntary and compulsory licensing. Some of these mechanisms have been effective, but much room for improvement remains. We discuss the usefulness of a new type of license that uses market forces to lower prices through generic competition in low- and middle-income countries while ensuring that pharmaceutical companies are appropriately reimbursed for their research and development.

Keywords:
Publication Types: Research Support, Non-U.S. Gov't MeSH Terms: Developing Countries/economics* Drug Industry/economics* Drug Industry/legislation & jurisprudence Economic Competition Female Health Services Accessibility/economics* Humans Licensure/legislation & jurisprudence* Papillomavirus Vaccines/economics* Papillomavirus Vaccines/supply & distribution Prescription Fees/legislation & jurisprudence* Research Support as Topic Substances: Papillomavirus Vaccines